Edmond de Rothschild Holding’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.7M | Buy |
649,420
+85,890
| +15% | +$4.72M | 0.57% | 47 |
|
|
2025
Q1 | $39.8M | Hold |
563,530
| – | – | 0.7% | 37 |
|
|
2024
Q4 | $37M | Buy |
563,530
+150,303
| +36% | +$9.88M | 0.63% | 39 |
|
|
2024
Q3 | $29M | Buy |
413,227
+224,000
| +118% | +$15.7M | 0.47% | 61 |
|
|
2024
Q2 | $15.6M | Hold |
189,227
| – | – | 0.26% | 92 |
|
|
2024
Q1 | $16.5M | Sell |
189,227
-30,306
| -14% | -$2.65M | 0.28% | 95 |
|
|
2023
Q4 | $21.2M | Buy |
219,533
+10
| +0% | +$964 | 0.38% | 70 |
|
|
2023
Q3 | $19.4M | Buy |
219,523
+71,217
| +48% | +$6.3M | 0.39% | 68 |
|
|
2023
Q2 | $12.9M | Buy |
148,306
+58,506
| +65% | +$5.07M | 0.25% | 97 |
|
|
2023
Q1 | $8.73M | Buy |
89,800
+15,000
| +20% | +$1.46M | 0.2% | 125 |
|
|
2022
Q4 | $7.74M | Sell |
74,800
-10,730
| -13% | -$1.11M | 0.18% | 128 |
|
|
2022
Q3 | $7.25M | Buy |
85,530
+28,800
| +51% | +$2.44M | 0.19% | 130 |
|
|
2022
Q2 | $4.7M | Buy |
56,730
+55,386
| +4,121% | +$4.59M | 0.11% | 157 |
|
|
2022
Q1 | $104K | Sell |
1,344
-525
| -28% | -$40.6K | ﹤0.01% | 586 |
|
|
2021
Q4 | $165K | Sell |
1,869
-130
| -7% | -$11.5K | ﹤0.01% | 564 |
|
|
2021
Q3 | $155K | Sell |
1,999
-4,830
| -71% | -$375K | ﹤0.01% | 574 |
|
|
2021
Q2 | $570K | Sell |
6,829
-65
| -0.9% | -$5.43K | 0.01% | 417 |
|
|
2021
Q1 | $521K | Buy |
+6,894
| New | +$521K | 0.01% | 383 |
|